Changes to Siegfried's Board of Directors 05.02.2026, 06:30 Uhr von EQS News Jetzt kommentieren: 0

Werte zum Artikel
Name Aktuell Diff. Börse
Siegfried Holding 98,25 EUR -0,51 % Lang & Schwarz

Siegfried AG / Key word(s): Personnel
Changes to Siegfried's Board of Directors

05-Feb-2026 / 06:30 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.


Media Release
Zofingen, February 5, 2026

Ad hoc announcement pursuant to Art. 53 Listing Rules

Siegfried (SIX: SFZN), a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry, today announced the nomination of Thomas Wozniewski and Karl Petersson as members of the Board of Directors.

Thomas Wozniewski has served as Takeda’s Global Manufacturing & Supply Officer, Chairman of the Board for Takeda Pharmaceuticals International in Switzerland and as a member of Takeda’s Executive Team since 2014 and will retire from this role in March 2026. During his time at Takeda, he focused on the technological and digital transformation, and the implementation of a continuous improvement culture within the global network of more than 25 manufacturing sites. Prior to joining Takeda, Thomas gained more than 25 years of experience in the pharmaceutical industry, holding senior leadership roles in manufacturing, quality and supply chain management at Bayer Consumer Care Switzerland, Bayer Healthcare AG, Schering AG and Boehringer Ingelheim in Germany.

Karl Petersson is a Senior Investment Director at Interogo Long-Term Equity, one of Siegfried’s largest shareholders. He is a non-executive member of the Board of Asker Healthcare Group AB, a Swedish-listed leading provider of medical products and solutions, and an Interogo investment. Before joining Interogo Long-Term Equity in 2025, Karl worked for nearly 10 years at the private equity firm Nordic Capital.

The Board will propose their elections to shareholders at the Siegfried Annual General Meeting on April 16, 2026. As previously communicated, Chairman Andreas Casutt will not stand for re-election, and will be succeeded by Beat Walti, pending his election at the 2026 AGM.

Andreas Casutt, Chairman of the Board of Directors: "We are pleased to nominate Thomas Wozniewski and Karl Petersson to Siegfried's Board of Directors. Thomas brings long-standing experience in pharmaceutical manufacturing and global supply management. Karl brings a strong understanding of capital markets and investment-related matters. Together, they will further strengthen the Board’s industry expertise and strategic perspective."

Siegfried nominates Thomas Wozniewski and Karl Petersson for election to the Board of Directors.

Contact  
   
Financial analysts: Media:
Dr. Reto Suter Peter Stierli
Chief Financial Officer Head Corporate Communications
reto.suter@siegfried.ch peter.stierli@siegfried.ch
Tel. +41 62 746 11 35 Tel. +41 62 746 15 51
   
Siegfried Holding AG  
Untere Bruehlstrasse 4  
CH-4800 Zofingen  

About Siegfried

The Siegfried Group is a global life sciences company with sites in Switzerland, Germany, Spain, France, Malta, the USA and China. In 2024, the company achieved sales of CHF 1.295 billion and employed on 31.12.2024 more than 3,800 people at thirteen sites on three continents. Siegfried Holding AG is publicly listed on SIX Swiss Exchange (SIX: SFZN). 

Siegfried is active in manufacturing pharmaceutical APIs (and their intermediates) as well as drug products (tablets, capsules, sterile vials, ampoules, cartridges and ointments) for the pharmaceutical industry and provides development services.



Cautionary statements regarding forward-looking statements


This media release includes statements concerning the future. They are based on assumptions and expectations that may prove to be wrong. They should be considered with due caution as, by definition, they contain known and unknown risks, insecurities and other factors which could result in a difference in the actual results, financial situation, developments or the success of Siegfried Holding AG or Siegfried Group from the explicit or implicit assumptions made in these statements.

expect more
 

Siegfried AG
Untere Brühlstrasse 4
4800 Zofingen, Switzerland

+41 62 746 11 11

info@siegfried.ch
www.siegfried.ch



End of Inside Information
Language: English
Company: Siegfried AG
Untere Brühlstrasse 4
4800 Zofingen
Switzerland
Phone: +41 62 746 11 11
E-mail: info@siegfried.ch
Internet: https://www.siegfried.ch
ISIN: CH1429326825
Listed: SIX Swiss Exchange
EQS News ID: 2266280

 
End of Announcement EQS News Service

2266280  05-Feb-2026 CET/CEST

Kommentare (0) ... diskutiere mit.
Werbung

Handeln Sie Aktien bei SMARTBROKER+ für 0 Euro!* Profitieren Sie von kostenloser Depotführung, Zugriff auf 29 deutsche und internationale Börsenplätze und unschlagbar günstigen Konditionen – alles in einer innovativen, brandneuen App. Jetzt zu SMARTBROKER+ wechseln und durchstarten!

*Ab 500 EUR Ordervolumen über gettex. Zzgl. marktüblicher Spreads und Zuwendungen.

k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer